ANG Lifesciences India Ltd - Stock Valuation and Financial Performance

BSE: 540694 | NSE: | Pharmaceuticals & Drugs | Small Cap

ANG Lifesciences Share Price

45.08 -1.75 -3.74%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on ANG Lifesciences

M-Cap below 100cr DeciZen not available

ANG Lifesciences India stock performance -

mw4me loader
P/E Ratio (SA):
0.00
Market Cap:
58.9 Cr.
52-wk low:
44.5
52-wk high:
92.2

Is ANG Lifesciences India Ltd an attractive stock to invest in?

1. Is ANG Lifesciences India Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that ANG Lifesciences India Ltd is a good quality company.

2. Is ANG Lifesciences India Ltd undervalued or overvalued?

The key valuation ratios of ANG Lifesciences India Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is ANG Lifesciences India Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of ANG Lifesciences India Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of ANG Lifesciences:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
ANG Lifesciences India Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 8.2%10.5%17%21.6%16.4%16.9%16.7%14.4%40%5.1%-
Value Creation
Index
-0.4-0.30.20.50.20.20.20.01.9-0.6-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 34.536.854.967.776122127154349207129
Sales YoY Gr.-6.8%49.1%23.2%12.4%60.1%4.2%21.6%126%-40.6%-
Adj EPS 0.20.41.83.12.94.54.95.630.7-0.3-7.7
YoY Gr.-109.5%309.1%70.6%-6.5%57.1%9.5%13.2%449.9%-100.9%-
BVPS (₹) 33.45.28.117.922.226.731.964.465.561.7
Adj Net
Profit
0.20.41.72.83.75.86.47.339.8-0.4-10
Cash Flow from Ops. 3.63.11.94.50.97.54.8-11.227.426-
Debt/CF from Ops. 3.43.87.3321.22.94.3-3.82.22-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 22%22.2%17.7%-40.6%
Adj EPS -203.3%-162.8%-138.4%-100.9%
BVPS41.1%29.7%34.9%1.7%
Share Price - 18.6% 9.4% -40.1%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
7.713.94246.124.322.520.219.163.8-0.4-12.1
Op. Profit
Mgn %
14.28.58.6109.91010.49.918.95.9-4.9
Net Profit
Mgn %
0.61.134.24.94.85.14.711.4-0.2-7.8
Debt to
Equity
4.53.82.81.80.80.80.610.70.6-
Working Cap
Days
130158139168198152180223155299241
Cash Conv.
Cycle
2920142851567265369832

Recent Performance Summary

Sales growth is growing at healthy rate in last 3 years 17.74%

Debt to equity has declined versus last 3 years average to 0.62

Return on Equity is Poor

Sales growth is not so good in last 4 quarters at -51.88%

Latest Financials - ANG Lifesciences India Ltd.

Standalone Consolidated
TTM EPS (₹) -7.7 -8.5
TTM Sales (₹ Cr.) 129 148
BVPS (₹.) 61.7 61.2
Reserves (₹ Cr.) 68 67
P/BV 0.73 0.74
PE 0.00 0.00
From the Market
52 Week Low / High (₹) 44.49 / 92.19
All Time Low / High (₹) 10.62 / 640.36
Market Cap (₹ Cr.) 58.9
Equity (₹ Cr.) 13.1
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of ANG Lifesciences:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *42.2521.1142.2044.8844.8844.8844.8844.8844.8844.88
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of ANG Lifesciences

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales34.5036.8454.9267.6776.04121.70126.83154.28348.67207.01
Operating Expenses 29.6133.7350.1960.9068.54109.87114.15138.94283.12195.35
Manufacturing Costs0004.245.207.558.9510.4714.7612.12
Material Costs25.5126.8140.8647.7752.8987.8488.97103.96230.01146.90
Employee Cost 1.202.373.474.125.646.397.2414.3518.3220.27
Other Costs 2.904.555.874.774.818.098.9910.1620.0316.05
Operating Profit 4.893.114.736.777.5011.8312.6815.3365.5411.66
Operating Profit Margin (%) 14.2%8.4%8.6%10.0%9.9%9.7%10.0%9.9%18.8%5.6%
Other Income 0.120.090.210.250.690.230.420.750.959.84
Interest 1.511.661.662.042.042.833.463.988.3110.92
Depreciation 3.050.951.061.171.191.121.232.245.128.52
Exceptional Items 0000000000
Profit Before Tax 0.450.602.223.814.958.118.419.8653.062.07
Tax 0.250.200.570.991.232.462.312.6113.352.73
Profit After Tax 0.190.401.652.823.725.656.107.2539.71-0.66
PAT Margin (%) 0.6%1.1%3.0%4.2%4.9%4.6%4.8%4.7%11.4%-0.3%
Adjusted EPS (₹)0.20.41.83.12.94.44.75.630.7-0.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%3%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 2.713.124.777.4923.1728.7734.5641.3683.4885.54
Share Capital 3.683.683.683.685.185.185.185.1810.3713.06
Reserves -0.97-0.571.093.8117.9923.5829.3736.1773.1172.48
Minority Interest0000000000
Debt11.0310.1411.7711.5814.0818.6918.1739.2153.5949.92
Long Term Debt9.778.116.814.967.686.285.255.9312.0110.06
Short Term Debt1.262.034.966.616.4012.4112.9233.2841.5939.85
Trade Payables9.289.7215.0821.3922.3221.8125.7945.2466.2761.95
Others Liabilities 22.823.876.388.6011.6215.5616.0365.3455.11
Total Liabilities 25.0225.8035.4946.8468.1780.9094.08141.83268.68252.51

Fixed Assets

Gross Block15.1715.8817.1818.3031.5632.4133.9637.54103.07107.94
Accumulated Depreciation6.147.108.169.3310.5211.6512.7915.6520.7529.26
Net Fixed Assets9.048.789.028.9721.0420.7621.1721.8982.3278.68
CWIP 00000000.4000
Investments 0.020.020.020.020.020.020.020.023.523.52
Inventories5.876.185.245.847.746.541019.2629.1737.39
Trade Receivables7.536.2816.3825.5632.1541.7546.0658.7898.9978.11
Cash Equivalents 0.550.471.030.911.484.373.600.116.596.05
Others Assets2.024.083.805.545.737.4613.2241.3648.1048.75
Total Assets 25.0225.8035.4946.8468.1780.9094.08141.83268.68252.51

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 3.583.131.864.510.887.464.83-11.1827.3926.01
PBT 0.450.602.222.823.728.118.419.8653.062.07
Adjustment 4.522.582.673.6943.404.105.8714.8318.34
Changes in Working Capital -1.290.03-2.61-1.13-5.81-1.68-5.02-26.29-39.928.96
Tax Paid -0.09-0.08-0.42-0.87-1.03-2.37-2.65-0.63-0.58-3.36
Cash Flow From Investing Activity -2.14-2.32-2.92-1.15-13.40-0.77-1.66-7.79-42.50-9.35
Capex -0.67-0.70-1.31-1.12-13.26-0.84-1.64-4.07-39.35-10.43
Net Investments 0000000-3.92-3.430.45
Others -1.46-1.61-1.61-0.03-0.140.07-0.010.200.280.63
Cash Flow From Financing Activity -1.43-0.891.63-3.4813.10-3.80-3.9518.8115.29-16.75
Net Proceeds from Shares 000012.0100002
Net Proceeds from Borrowing -1.23-1.66-1.30-1.852.72-1.41-1.032.3410.40-6.51
Interest Paid 000-1.53-1.58-2.34-2.87-3.58-6.60-10.19
Dividend Paid 00000000-1.040
Others -0.200.772.93-0.10-0.05-0.05-0.0520.0512.52-2.04
Net Cash Flow 0.02-0.080.56-0.120.572.89-0.77-0.160.17-0.08
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)7.7413.8641.9746.0624.2921.7519.2519.163.62-0.78
ROCE (%)12.8115.1523.3629.6622.2323.6622.3919.953.789.18
Asset Turnover Ratio1.51.451.791.641.321.631.451.311.70.79
PAT to CFO Conversion(x)18.847.831.131.60.241.320.79-1.540.69N/A
Working Capital Days
Receivable Days62687511313811112612483156
Inventory Days53603830332124352559
Payable Days104129111139151929812588159

ANG Lifesciences India Ltd Stock News

ANG Lifesciences India Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of ANG Lifesciences on 28-Mar-2024 16:01 is ₹45.08.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of ANG Lifesciences stood at ₹58.87.
The latest P/E ratio of ANG Lifesciences as of 28-Mar-2024 16:01 is 0.00.
The latest P/B ratio of ANG Lifesciences as of 28-Mar-2024 16:01 is 0.73.
The 52-week high of ANG Lifesciences is ₹92.19 and the 52-week low is ₹44.49.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of ANG Lifesciences is ₹129.2 ( Cr.) .

About ANG Lifesciences India Ltd

No data to display
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.